Evidence map›Paper›PMID 39456162›Full record

ArticleBiomolecules2024

Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5'-G

Aashrita Manjunath, Jeff Cheng, Kristen B Campbell, Casey S Jacobsen, Herra G Mendoza, Leila Bierbaum, Victorio Jauregui-Matos, Erin E Doherty, Andrew J Fisher, Peter A Beal

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aashrita ManjunathDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0009-0007-9999-6176
Jeff ChengDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0002-2846-3205
Kristen B CampbellDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0002-3847-8080
Casey S JacobsenDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0002-0249-1398
Herra G MendozaDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0003-3151-9772
Leila BierbaumDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.
Victorio Jauregui-MatosDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0003-2009-5521
Erin E DohertyDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.
Andrew J FisherDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0003-3488-6594
Peter A BealDepartment of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, USA.

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Supplement:High-throughput screening and structure-guided optimization of oligonucleotides for site-directed RNA editing by ADARsR01GM149799 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ANDREW J FISHER · 2023 to 2026
$1.4M
Site-directed RNA Editing to Modulate Kinase Activity as a ChemotherapeuticF31CA265135 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DOHERTY, ERIN E · 2021 to 2021
$38k
National Institute of Food and Agriculture CA-D-MCB-2629-HNational Science Foundation NSF GRFP 165004NCI NIH HHS F31 CA265135NCI NIH HHS F31CA265135-01NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM149799NIH HHS R01 GM149799
6 · The paper itself

Abstract

Adenosine Deaminases Acting on RNA (ADARs) are members of a family of RNA editing enzymes that catalyze the conversion of adenosine into inosine in double-stranded RNA (dsRNA). ADARs' selective activity on dsRNA presents the ability to correct mutations at the transcriptome level using guiding oligonucleotides. However, this approach is limited by ADARs' preference for specific sequence contexts to achieve efficient editing. Substrates with a guanosine adjacent to the target adenosine in the 5' direction (5'-GA) are edited less efficiently compared to substrates with any other canonical nucleotides at this position. Previous studies showed that a G/purine mismatch at this position results in more efficient editing than a canonical G/C pair. Herein, we investigate a series of modified oligonucleotides containing purine or size-expanded nucleoside analogs on guide strands opposite the 5'-G (-1 position). The results demonstrate that modified adenosine and inosine analogs enhance editing at 5'-GA sites. Additionally, the inclusion of a size-expanded cytidine analog at this position improves editing over a control guide bearing cytidine. High-resolution crystal structures of ADAR:/RNA substrate complexes reveal the manner by which both inosine and size-expanded cytidine are capable of activating editing at 5'-GA sites. Further modification of these altered guide sequences for metabolic stability in human cells demonstrates that the incorporation of specific purine analogs at the -1 position significantly improves editing at 5'-GA sites.

Indexed as

AdenosineAdenosine DeaminaseRNA EditingGuanosineHEK293 CellsHumansInosineNucleosidesRNA-Binding ProteinsRNA, Double-StrandedRNA, Guide, CRISPR-Cas SystemsADAR protein, humanAdenosineAdenosine DeaminaseGuanosineInosineNucleosidesRNA-Binding ProteinsRNA, Double-StrandedRNA, Guide, CRISPR-Cas SystemsADARNucleoside analogRNA editing

Identifiers

PMID39456162
PMCPMC11506087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.